Brief: Nova Eye Medical Announces Deferral Of Proposed USA Medicare Changes
08/12/2023 01:01
Dec 8 (Reuters) - Nova Eye Medical Ltd EYE.AX :
* DEFERRAL OF PROPOSED USA MEDICARE CHANGES
* DEFERRAL ALLOWS TIME TO EXECUTE INITIATIVES TO OVERCOME
CHALLENGES IMPOSED BY PROPOSED LCD CHANGES, SHOULD THEY BE
IMPLEMENTED
* DEFERRAL BY ALL FIVE MACS IS A POSITIVE OUTCOME FOR
NEAR-TERM
SALES OF CO'S ITRACK PORTFOLIO OF CANALOPLASTY DEVICES
Source text for Eikon: ID:nASX55qNTR
Further company coverage: EYE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment